Are you passionate about driving operational efficiency in clinical operations? Join us as a dynamic Senior Process Engineer to revolutionize our clinical production processes and build out workflows for our team of medical imaging analysts. In this pivotal role, you'll develop key operational metrics, design seamless workflows, and foster team and cross-functional collaboration. You'll work hand-in-hand with our talented 3D CT analysts, as well as our Clinical QA, Software QA, and Product Management teams to propel our clinical operations to new heights as we rapidly scale and commercialize. Be part of our mission to advance cardiac care, at the forefront of transforming clinical operations in a fast-paced, cutting-edge environment!
The ideal candidate will have:
- Bachelor's degree in Engineering, Biomedical Engineering, or a related field.
- 5+ years of experience in process engineering or an operational optimization role with software-as-a-medical-device (SaMD) or medical imaging products.
- Lean and/or Six Sigma experience.
- Strong eye for optimization and a mindset of continuous improvement.
- Excellent problem-solving and analytical skills.
- Strong communication and collaboration abilities.
- Detail-oriented, with a focus on quality and compliance.
- This role is based out of our office in Boston, MA. We operate in a hybrid model with regular in-office collaboration.
- The anticipated base salary range for this position at Elucid is $135,00-$165,000. Compensation will be influenced by a wide array of factors including but not limited to internal pay equity, job-related knowledge, skills, education, relevant experience, certifications, and geography as outlined in the job description.
Top Skills
What We Do
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe
